Page 122 - Demo

16. Jindal, A.; Sarkar, S.; Alam, A. Nanomaterials-Mediated Immunomodulation forCancer Therapeutics. Front Chem 2021, 9.https://doi.org/10.3389/fchem.2021.629635.17. Rios-Doria, J.; Durham, N.; Wetzel, L.; Rothstein, R.; Chesebrough, J.;Holoweckyj, N.; Zhao, W.; Leow, C. C.; Hollingsworth, R. Doxil Synergizeswith Cancer Immunotherapies to Enhance Antitumor Responses in SyngeneicMouse Models. Neoplasia 2015, 17 (8), 661%u2013670.https://doi.org/10.1016/j.neo.2015.08.004.18. Wells, K.; Liu, T.; Zhu, L.; Yang, L. Immunomodulatory Nanoparticles ActivateCytotoxic T Cells for Enhancement of the Effect of Cancer Immunotherapy.Nanoscale 2024, 16 (38), 17699%u201317722.https://doi.org/10.1039/D4NR01780C.19. Nguyen, V. Du; Min, H.-K.; Kim, D.-H.; Kim, C.-S.; Han, J.; Park, J.-O.; Choi,E. Macrophage-Mediated Delivery of Multifunctional Nanotherapeutics forSynergistic Chemo%u2013Photothermal Therapy of Solid Tumors. ACS Appl MaterInterfaces 2020, 12 (9), 10130%u201310141.https://doi.org/10.1021/acsami.9b23632.20. Jiang, Y.; Fan, M.; Yang, Z.; Liu, X.; Xu, Z.; Liu, S.; Feng, G.; Tang, S.; Li, Z.;Zhang, Y.; Chen, S.; Yang, C.; Law, W.-C.; Dong, B.; Xu, G.; Yong, K.-T. RecentAdvances in Nanotechnology Approaches for Non-Viral Gene Therapy.Biomater Sci 2022, 10 (24), 6862%u20136892.https://doi.org/10.1039/D2BM01001A.21. Roma-Rodrigues, C.; Rivas-Garc%u00eda, L.; Baptista, P. V.; Fernandes, A. R. GeneTherapy in Cancer Treatment: Why Go Nano? Pharmaceutics 2020, 12 (3),233. https://doi.org/10.3390/pharmaceutics12030233.22. Shi, J.; Kantoff, P. W.; Wooster, R.; Farokhzad, O. C. Cancer Nanomedicine:Progress, Challenges and Opportunities. Nat Rev Cancer 2017, 17 (1), 20%u201337.https://doi.org/10.1038/nrc.2016.108.23. Huang, B. W.; Gao, J. Q. Application of 3D Cultured Multicellular SpheroidTumor Models in Tumor-Targeted Drug Delivery System Research. Journal ofControlled Release 2018, 270 (August 2017), 246%u2013259.https://doi.org/10.1016/j.jconrel.2017.12.005.24. Barriga, V.; Kuol, N.; Nurgali, K.; Apostolopoulos, V. The Complex Interactionbetween the Tumor Micro-Environment and Immune Checkpoints in BreastCancer. Cancers (Basel) 2019, 11 (8).https://doi.org/10.3390/cancers11081205.25. Wang, L.; Zhu, B.; Zhang, M.; Wang, X. Roles of Immune MicroenvironmentHeterogeneity in Therapy-Associated Biomarkers in Lung Cancer. Semin CellDev Biol 2017, 64, 90%u201397. https://doi.org/10.1016/j.semcdb.2016.09.008.26. Son, B.; Lee, S.; Youn, H.; Kim, E.; Kim, W.; Youn, B. The Role of TumorMicroenvironment in Therapeutic Resistance. Oncotarget 2017.https://doi.org/10.18632/oncotarget.13907.27. Nicolas-Boluda, A.; Silva, A. K. A.; Fournel, S.; Gazeau, F. Physical Oncology:New Targets for Nanomedicine. Biomaterials 2018, 150, 87%u201399.https://doi.org/10.1016/j.biomaterials.2017.10.014.120Potential of 3D tumor models for nanotherapies pre-clinical screeningVitor M. Gaspar1, Jo%u00e3o F. Mano, et al.